Bio-rad laboratories, inc. (BIO)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10
Cash flows from operating activities:
Cash received from customers

569,001

595,439

573,264

592,931

550,291

610,350

555,056

571,035

589,869

575,891

518,278

490,797

508,982

543,419

510,456

527,742

492,407

512,412

472,056

493,137

478,479

548,797

526,236

543,040

544,447

558,779

524,906

502,187

504,158

550,814

504,476

507,440

501,075

509,821

488,652

523,533

496,749

509,706

476,119

445,989

445,669

Cash paid to suppliers and employees

509,683

425,922

460,644

424,849

507,160

494,891

487,229

463,865

543,700

485,748

461,652

418,430

550,289

443,139

429,961

426,767

508,820

451,807

379,498

444,771

453,986

453,872

427,120

454,082

471,452

468,184

424,617

451,134

460,093

436,580

392,737

406,441

428,733

390,174

406,844

406,400

436,430

393,236

364,235

1,168,969

-389,505

Interest paid, net

231

10,949

296

10,626

459

10,982

444

10,899

378

10,827

532

10,919

-54

11,561

284

10,724

187

11,173

549

9,542

-471

10,036

-155

10,620

292

11,045

25,507

13,006

11,675

10,440

11,828

11,761

12,340

10,773

12,790

11,107

22,189

11,022

20,951

48,947

-21,086

Income tax payments, net

4,528

2,447

18,618

19,449

4,567

4,574

10,220

44,375

3,245

12,315

20,755

10,262

8,804

1,069

26,288

21,506

-10,421

16,069

9,377

7,772

-1,503

-2,166

14,046

10,150

6,909

11,424

17,618

27,907

14,195

16,286

29,792

22,609

25,010

30,721

19,320

336

18,373

5,248

22,085

41,448

-13,279

Investment proceeds and miscellaneous receipts, net

3,912

3,581

3,999

19,597

4,496

4,782

3,247

16,196

2,158

4,054

1,141

11,914

1,283

237

1,550

11,143

1,667

2,258

1,035

7,485

1,175

4,308

1,080

9,000

1,283

3,834

2,000

8,941

1,985

3,562

1,599

7,221

609

1,562

1,719

5,141

1,264

432

170

2,330

693

Excess tax benefits from share-based compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

406

1,019

8

67

368

1,984

46

1,212

583

298

286

182

1,912

309

393

106

1,964

376

208

341

1,138

259

532

1,239

244

2,152

755

-223

Proceeds from forward foreign exchange contracts, net

-4,337

470

-2,045

2,202

-342

14,882

-1,867

-9,770

4,358

-33,758

8,005

600

7,429

-9,605

14,035

-2,725

-2,869

699

596

6,074

-3,016

11,070

-4,647

30

1,325

2,440

4,023

-1,049

-3,943

1,452

4,622

-4,614

1,410

-6,500

-6,949

2,911

7,619

-1,977

11,915

-17,755

4,606

Net cash provided by operating activities

62,800

159,800

99,800

155,400

42,900

105,000

62,300

77,900

40,300

69,328

28,475

62,500

-56,203

94,786

51,607

77,155

-7,448

35,952

82,279

38,533

29,446

40,216

90,654

76,872

65,570

70,550

54,832

19,737

24,017

86,236

71,342

73,642

35,260

81,496

51,158

110,299

19,782

100,388

66,866

36,386

22,269

Cash flows from investing activities:
Capital expenditures

21,591

21,598

31,091

22,214

23,629

53,874

22,054

26,713

27,184

26,068

20,313

25,619

39,332

45,113

39,458

31,569

25,296

27,987

24,744

32,189

27,080

40,134

27,355

30,929

22,581

27,720

20,340

24,495

34,103

30,503

36,669

41,043

34,654

35,655

24,676

24,748

17,809

-

-

-

-

Proceeds from dispositions of property, plant and equipment

38

44

-1

12

74

42

173

4,082

18

24

41

6

15

20

357

20

1

38

12

25

4

-156

43

224

114

-38

164

1,062

26

6,094

117

114

0

57

63

91

23

681

190

35

284

Payments for acquisitions and long-term investments

-

-

-

-

-

-

-

-

-

-

1,301

32

73,541

-

308

1,843

9,634

866

901

1,694

895

982

1,635

40,646

1,364

3,544

2,627

1,827

64,056

964

19,890

3,260

15,329

149,840

3,470

1,657

3,571

613

21,349

133,841

-66,496

Recovery of (payments for) purchases of intangible assets

-

-

-

-

-

0

0

0

3

-

-

-

-

-

-

-

-

-3

54

14

1,307

-9

106

3,024

12,358

200

0

37

463

56

491

988

245

-3

296

40

103

1,366

684

3,712

-1,681

Payments for purchases of intangible assets

-

-

-

-

-

-

-

-

-

-

-130

3,920

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-16,409

Payments for purchases of marketable securities and investments

98,151

104,611

95,224

76,240

95,375

84,193

103,825

121,558

61,443

48,890

90,773

74,688

68,305

60,251

69,397

76,938

71,485

122,057

61,148

44,724

66,568

46,139

60,534

53,800

45,273

61,678

48,201

129,864

146,971

133,437

144,721

217,340

185,468

126,552

144,774

148,238

89,746

61,570

69,260

158,717

-49,261

Proceeds from maturities of marketable securities and investments

67,710

45,792

42,864

55,671

82,573

66,673

70,212

42,924

45,486

50,987

52,881

47,809

50,570

40,908

38,076

28,861

35,175

49,267

44,108

36,949

40,499

20,924

29,260

48,716

21,490

41,345

67,133

90,474

77,100

55,902

61,950

86,100

123,100

134,856

106,000

56,100

38,825

45,122

61,381

44,997

51,943

Proceeds from sales of marketable securities and investments

-

-

-

-

-

16,541

25,940

17,157

17,391

13,640

44,521

19,161

20,201

17,172

17,301

22,005

20,381

22,034

15,492

13,782

27,356

17,034

13,816

20,473

24,402

12,390

178,801

38,403

60,185

41,924

40,400

21,250

27,721

1,107

4,391

40,620

2,707

-

-

-

-

Proceeds from Sale of Debt Securities, Available-for-sale

39,672

-

-

-

22,324

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments for Previous Acquisition

0

-

-

-

16,083

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from divestiture of a product line

-

-

-

-

-

0

45

0

6,919

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(Payments for) proceeds from Other Investing Activities

100

-

59,728

23,486

-7,403

-

0

-266

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

-12,422

-61,196

-109,909

-15,071

-22,713

-54,811

-29,509

-83,842

-18,816

-13,083

-14,814

-37,283

-110,392

-50,123

-53,429

-59,470

-50,858

-83,778

-27,235

-27,865

-27,991

-49,444

-46,511

-58,986

-35,570

-39,445

174,930

-26,284

-108,282

-59,622

-103,926

-150,553

-86,285

-172,443

-55,813

-80,783

-77,293

-52,102

-61,261

-26,135

-77,014

Cash flows from financing activities:
Net payments on line-of-credit arrangements and notes payable

-

-

-

-

-

-

-

-

-

0

0

0

-36

37

0

0

0

-

-

-

-

-1,198

-300

-12

-50

66

0

1

-19

22

-439

87

139

-3,869

-529

2,883

-2,385

-1,292

13

740

-291

Payments on long-term borrowings

1,415

156

128

122

237

1,366

90

1,418

87

96

71

73

76

72

75

79

77

76

75

65

66

72

63

52

66

50

300,055

49

74

124

129

142

225

220

247

605

225,763

201,265

2,501

4,535

-1,595

Payments for credit agreement renewal fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

242

-

-

-

-

Payments of contingent consideration

1,265

0

1,044

0

1,433

0

808

0

1,270

0

576

0

3,105

0

0

0

3,500

0

0

0

2,983

2,374

0

0

0

0

12,400

2,500

10,574

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from Issuances of common stock for shared-based compensation

4,068

3,373

5,828

3,912

0

3,275

3,746

3,240

3,872

10,982

-156

-112

3,890

2,452

1,953

3,107

3,768

3,510

140

3,080

1,506

6,686

1,892

3,049

3,424

1,840

2,817

3,445

3,135

1,653

2,746

2,748

3,464

1,218

2,573

2,820

7,638

3,713

3,394

2,927

2,696

Proceeds from Sale of Treasury Stock

0

-

-

-

3,831

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from reissuances of treasury stock for shared-based compensation, net

-

-

-

-

-

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments for purchases of treasury stock

100,005

8,000

4,999

15,001

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Excess tax benefits from share-based compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

412

1,019

8

67

368

1,984

46

1,212

583

298

286

182

1,912

309

393

106

1,964

376

208

341

1,138

259

532

1,239

244

2,152

309

223

Net cash (used in) provided by financing activities

-98,617

-4,783

-4,491

-15,645

2,161

-47,003

-2,176

-2,016

2,515

3,576

-2,840

-1,068

673

2,829

2,897

3,036

258

3,728

2,123

3,061

-331

3,625

1,766

2,808

3,490

3,768

-309,329

1,290

-7,426

3,515

2,554

2,800

3,719

-1,733

2,056

860

-214,743

221,522

3,032

3,158

1,033

Effect of Exchange Rate on Cash and Cash Equivalents

-5,977

5,476

-5,366

145

1,982

-4,620

912

4,436

-1,383

-4,917

-3,367

5,852

1,338

-9,500

-1,787

-5,685

4,114

-5,682

29

10,676

11,353

-5,739

-5,986

-531

-534

4,885

4,361

3,627

-3,068

6,802

0

-3,214

6,887

-4,117

3,326

12,017

-6,389

6,103

7,780

2,680

1,908

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect

-54,208

99,299

-20,016

124,831

24,373

-1,425

31,504

-3,560

22,662

54,941

7,454

30,001

-164,584

37,958

-712

15,036

-53,934

-49,780

57,196

24,405

12,477

-11,342

39,923

20,163

32,956

39,758

-75,206

-1,630

-94,759

36,931

-30,030

-77,325

-40,419

-96,797

727

42,393

-278,643

275,911

16,417

16,089

-51,804

Adjustments to reconcile net income to net cash used in operating activities [Abstract]
Net income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

18,405

18,014

12,276

-

17,370

28,423

17,818

-

11,509

31,631

6,668

-

-7,099

34,602

20,172

-

42,864

48,565

30,944

-

45,862

40,022

32,938

-

45,085

38,521

35,392

Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

38,488

37,578

34,090

-

33,561

32,126

32,283

-

37,122

36,336

36,671

-

36,970

34,921

33,290

-

32,136

31,653

31,096

-

30,384

29,628

28,115

-

26,331

26,085

27,548

Share-based compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,911

4,762

4,645

-

4,004

4,234

4,071

-

3,332

3,681

3,701

-

3,113

3,299

3,482

-

2,922

3,190

3,136

-

2,512

2,521

2,783

-

2,533

2,538

2,286

Forward foreign exchange contracts, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4,622

4,614

-1,410

-

6,949

-2,911

-7,619

-

-11,915

17,755

-4,606

Losses (gains) on dispositions of securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

27

295

-229

-

-53

-142

214

-

-13

-216

-100

-

-511

-87

190

-

1,136

132

6,247

-

-783

-426

-51

-

-

-

-

Excess tax benefits from share-based compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

406

1,019

8

67

368

1,984

46

1,212

-

298

286

182

1,912

309

393

106

1,964

376

208

341

1,138

259

532

1,239

244

2,152

755

-223

Changes in fair value of contingent consideration

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-291

-589

-1,284

-

-825

1,287

-1,192

-

-3,039

-446

-4,893

-

-46

-590

-711

-

-8,437

-7,547

0

-

-

-

-

-

-

-

-

(Increase) decrease in accounts receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-583

-12,076

-19,991

-

-7,137

5,708

-15,567

-

-5,079

-6,501

-39,569

-

-21,280

20,931

-14,454

-

-4,952

-2,346

-17,582

-

1,033

-1,764

-10,901

-

8,264

12,076

-2,366

Increase in inventories

-

-

-

-

-

-

-

-

-

-

-

-

-

-

16,959

16,579

34,400

-

21,025

17,115

29,469

-

4,290

9,811

14,780

-

24,487

18,743

18,350

-

3,684

-207

15,502

-

20,509

9,100

20,685

-

8,675

20,562

-7,592

Increase in other current assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-543

-13,169

15,730

-

-3,840

-3,856

5,076

-

-3,714

-8,030

11,390

-

-3,308

-2,105

11,161

-

-4,347

4,097

4,617

-

-8,472

3,496

8,466

-

-13,047

25,815

-9,207

Decrease in accounts payable and other current liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

27,919

15,102

-47,666

-

40,972

-15,356

-7,747

-

40,747

-8,322

7,318

-

30,533

-2,110

-9,151

-

538

1,326

-7,780

-

-3,530

22,517

-31,861

-

5,827

43,629

-20,334

Decrease in income taxes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-8,434

-14,064

14,075

-

-2,092

10,746

6,106

-

-14,141

11,927

1,621

-

-4,029

-16,997

-9,684

-

-11,828

-4,455

-10,436

-

-5,502

15,592

-4,514

-

-10,842

2,802

6,753

Increase (decrease) in Deferred Income Taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

12,540

-666

-3,394

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net decrease/increase in other long-term assets/liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

140

-7,323

-2,999

-

1,457

3,681

1,489

-

-10,906

2,585

-1,167

-

4,913

-4,487

-1,972

-

-4,422

-7,408

3,985

-

-927

-8,046

-4,140

-

-3,715

12,388

-5,382